Prostate cancer regulator plays role in COVID-19, providing a promising treatment lead
By taking a lesson from prostate cancer, researchers now have a promising lead on a treatment for COVID-19.
Dec 21, 2020
0
110
By taking a lesson from prostate cancer, researchers now have a promising lead on a treatment for COVID-19.
Dec 21, 2020
0
110
Pre-clinical research into deadly brain cancer, Parkinson's, dementia, epilepsy and other major psychiatric and neurological conditions can speed up with the global commercialisation of an advanced neuromedium, called BrainPhys.
Nov 5, 2020
0
54
Age may cause identical cancer cells with the same mutations to behave differently. In animal and laboratory models of melanoma cells, age was a primary factor in treatment response.
Nov 2, 2020
0
36
Researchers at McMaster and Brock universities have created the prototype for a hand-held device to measure a biomarker for cancer, paving the way for home-based cancer monitoring and to improve access to diagnostic testing.
Oct 19, 2020
0
29
Oral cancer is more likely to spread in patients experiencing high levels of pain, according to a team of researchers at New York University (NYU) College of Dentistry that found genetic and cellular clues as to why metastatic ...
Oct 7, 2020
0
38
A new study has identified a key gene in aggressive endometrial cancer, which could lead to a targeted therapeutic strategy to improve survival rates.
Aug 18, 2020
0
139
A tumor test could help to identify ovarian cancer patients with predicted poor survival, and down the track inform new therapeutical approaches, the results of a major international collaboration have shown.
Aug 17, 2020
0
194
A recent innovation from an EPFL laboratory will enable, for the first time, mass production of standardized organoids. This breakthrough was achieved thanks to a customized guidance system that ensures homogenous cell culturing. ...
Jun 8, 2020
0
160
Early data from a clinical study suggest that blocking the Bruton tyrosine kinase (BTK) protein provided clinical benefit to a small group of patients with severe COVID-19. Researchers observed that the off-label use of the ...
Jun 5, 2020
1
279
Melbourne researchers have developed a new way to pinpoint which breast cancers will respond to a new class of anti-cancer agents called Smac-mimetics.
May 6, 2020
0
272